1. From the Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius), Department of Oncology, University Hospital, Linko ping (B. Nordenskjold), Department of Oncology, University Hospital, Lund (E. Kjellen) and the Department of Oncology, Umea University, Umea (B. Zackrisson), Sweden